Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - OPERATING INCOME
Operating Income NTLA - Intellia Therapeutics, Inc.
-515 M
LAST VALUE
-38.70%
2 YEAR CAGR
-41.49%
5 YEAR CAGR
0.00%
10 YEAR CAGR